Skip to main content

Samlyn Capital, LLC

SEC CIK
0001421097
Latest filing
Aug 14, 2026

JANX holding history

Janux Therapeutics, Inc. in every 13F filed by Samlyn Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

JANX overviewAll 13F holders of JANXFull Q2 2026 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q1 2024
Holdings of JANX by Samlyn Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−324,703−100.0%Sold outHolders
Q2 2024324,703$13.6M0.2%+28,312+9.6%AddedHolders
Q1 2024296,391$11.2M0.2%+296,391NewHolders